What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?

CMAJ. Canadian Medical Association Journal

Volumn 173, Issue 9, 2005, Pages 1024-1026

  Sudlow, Cathie ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIARRHEA; DRUG MECHANISM; HEADACHE; HUMAN; META ANALYSIS; PHYSICIAN; SHORT SURVEY; SIDE EFFECT; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK;

EID: 27544435636     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.050871     Document Type: Short Survey

References (5)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for the prevention of death myocardial cardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
2. EL De Schryver for the ESPRIT study group. Dipyridamole in stroke prevention: effect of dipyridamole on blood pressure. Stroke 2003;4:2339-42.
3. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European secondary prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
4. Leonardi-Bee J, Bath PM, Bousser MG, Davalos A, Diener HC, Guiraud-Chaumeil B, et al. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials [review]. Stroke 2005;36:162-8.
5. Diener HC, Darius H, Bertrand-Hardy JM, Humphreys M, for the European Stroke Prevention Study 2. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2). Int J Clin Pract 2001;55:162-3.